Researchers from the Zaragoza UNAM (National Autonomous University of Mexico) have announced the development of a new nanoparticle that selectively targets cervical cancer cells, while sparing healthy tissue from damage. The nanoparticles ferry interleukin-2 (IL -2), a protein that’s normally produced by the T-cells of the immune system to differentiate between foreign material and the body itself, and to direct the actions of white blood cells. It has also been used in various therapies to kill cancer cells.
Hey, check out all the engineering jobs. Post your resume today!
